BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 28219213)

  • 1. [Clinical application value of prognostic nutritional index for predicting survival in patients with advanced non-small cell lung cancer].
    Xu WJ; Kang YM; Zhou L; Chen FF; Song YH; Zhang CQ
    Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):146-149. PubMed ID: 28219213
    [No Abstract]   [Full Text] [Related]  

  • 2. Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs.
    Sheng J; Yang YP; Ma YX; Qin T; Hu ZH; Hong SD; Zhou T; Huang Y; Zhao HY; Zhang L
    PLoS One; 2016; 11(1):e0147226. PubMed ID: 26784943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Prognostic Nutritional Index in Patients Undergoing Radical Surgery with Nonsmall Cell Lung Cancer.
    Qiu C; Qu X; Shen H; Zheng C; Zhu L; Meng L; Du J
    Nutr Cancer; 2015; 67(5):741-7. PubMed ID: 25941961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Shoji F; Takeoka H; Kozuma Y; Toyokawa G; Yamazaki K; Ichiki M; Takeo S
    Lung Cancer; 2019 Oct; 136():45-51. PubMed ID: 31437663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients.
    Hong S; Zhou T; Fang W; Xue C; Hu Z; Qin T; Tang Y; Chen Y; Ma Y; Yang Y; Hou X; Huang Y; Zhao H; Zhao Y; Zhang L
    Tumour Biol; 2015 May; 36(5):3389-97. PubMed ID: 25527156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Significance of Prognostic Nutritional Index After Surgical Treatment in Lung Cancer.
    Okada S; Shimada J; Kato D; Tsunezuka H; Teramukai S; Inoue M
    Ann Thorac Surg; 2017 Jul; 104(1):296-302. PubMed ID: 28433217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Prognostic Value of "Neutrophil to Lymphocyte Ratio" and "Prognostic Nutritional Index" as a Sytemic Inflammatory Marker in Non-small Cell Lung Cancer.
    Kos FT; Hocazade C; Kos M; Uncu D; Karakas E; Dogan M; Uncu HG; Ozdemir N; Zengin N
    Asian Pac J Cancer Prev; 2015; 16(9):3997-4002. PubMed ID: 25987075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low pretreatment PNI correlates with worse survival in patients with stage III/IV NSCLC who received chemotherapy.
    Shen Y; Li H; Yuan ZQ; Ren MY; Yu SL; Liao YD; Cai JJ; Liu C; Chen BC; Wu AH; Li GF; Xie L
    Neoplasma; 2020 Mar; 67(2):394-401. PubMed ID: 31847525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer.
    Shoji F; Morodomi Y; Akamine T; Takamori S; Katsura M; Takada K; Suzuki Y; Fujishita T; Okamoto T; Maehara Y
    Lung Cancer; 2016 Aug; 98():15-21. PubMed ID: 27393501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlling Nutritional Status (CONUT) score is a prognostic marker in III-IV NSCLC patients receiving first-line chemotherapy.
    Zhang Y; Kong FF; Zhu ZQ; Shan HX
    BMC Cancer; 2023 Mar; 23(1):225. PubMed ID: 36894927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
    Song S; Liu H; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy.
    Nakatani M; Migita K; Matsumoto S; Wakatsuki K; Ito M; Nakade H; Kunishige T; Kitano M; Kanehiro H
    Dis Esophagus; 2017 Aug; 30(8):1-7. PubMed ID: 28575242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.
    Tong YS; Tan J; Zhou XL; Song YQ; Song YJ
    J Transl Med; 2017 Oct; 15(1):221. PubMed ID: 29089030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative prognostic nutritional index as a prognostic factor after non-small cell lung cancer surgery.
    Hayasaka K; Shiono S; Suzuki K; Endoh M; Okada Y
    Gen Thorac Cardiovasc Surg; 2020 Oct; 68(10):1163-1171. PubMed ID: 32328993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
    Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
    PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of prognostic nutritional index in advanced (stage IIIB/IV) non-small cell lung cancer patients.
    Li XL; Yao ZH; Wan YY; Mou XY; Ni YH; Sun EL; Zhang D; Lin DJ
    Neoplasma; 2019 Nov; 66(6):971-977. PubMed ID: 31390870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prognostic nutritional index (PNI) as a positive prognostic indicator for non-small cell lung cancer patients with bone metastasis.
    Xu S; Cao S; Geng J; Wang C; Meng Q; Yu Y
    Clin Respir J; 2021 Feb; 15(2):225-231. PubMed ID: 33037791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between nutritional status and prognosis in patients with locally advanced and advanced stage lung cancer.
    Gul B; Metintas S; Ak G; Yilmaz S; Metintas M
    Support Care Cancer; 2021 Jun; 29(6):3357-3365. PubMed ID: 33128137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel.
    Nishihara-Kato F; Imai H; Tsuda T; Wasamoto S; Nagai Y; Kishikawa T; Miura Y; Ono A; Yamada Y; Masubuchi K; Osaki T; Nakagawa J; Umeda Y; Minemura H; Kozu Y; Taniguchi H; Ohta H; Kaira K; Kagamu H
    Oncology; 2024; 102(1):30-42. PubMed ID: 37598676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.